These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 3710492)
41. [A network of regional correspondents for studying undesirable effects]. Haramburu F; Péré JC; Begaud B; Albin H Therapie; 1985; 40(5):321-4. PubMed ID: 4095688 [No Abstract] [Full Text] [Related]
42. Postmarketing surveillance. Oleen MA Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449 [TBL] [Abstract][Full Text] [Related]
43. [Critical analysis of the adverse effects reported to the Paris-Fernand Widal Drug Monitoring Center in a 2-month period]. Castot A; Carlier P; Lagier G; Elmalem J; Vincens M; Efthymiou M Therapie; 1986; 41(5):375-7. PubMed ID: 3810528 [No Abstract] [Full Text] [Related]
44. Adverse drug reaction reporting: a working system. Michelson PA; Shields K Hosp Pharm; 1987 Jul; 22(7):682-4. PubMed ID: 10282685 [TBL] [Abstract][Full Text] [Related]
45. Postmarketing surveillance of adverse reactions to drugs. Rawlins MD Br Med J (Clin Res Ed); 1984 Mar; 288(6421):879-80. PubMed ID: 6423125 [No Abstract] [Full Text] [Related]
46. [Comparative organization of drug monitoring in France and 7 European countries]. Vaissere J; de Cremiers F; Auriche M; Juillet Y Therapie; 1986; 41(5):369-74. PubMed ID: 3810527 [No Abstract] [Full Text] [Related]
47. [Comprehensive detection of severe, potentially life-threatening drug side effects]. Schönhöfer PS; Wessely-Stickel B; Schulte-Sasse H; Werner W Verh Dtsch Ges Inn Med; 1989; 95():687-90. PubMed ID: 2603504 [No Abstract] [Full Text] [Related]
48. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207 [TBL] [Abstract][Full Text] [Related]
49. Postmarketing surveillance of adverse reactions to drugs. Inman WHW Br Med J (Clin Res Ed); 1984 Apr; 288(6424):1155-6. PubMed ID: 6424767 [No Abstract] [Full Text] [Related]
50. [Is establishment of causality in drug surveillance reliable?]. Evreux JC Therapie; 1984; 39(4):437-8. PubMed ID: 6484888 [No Abstract] [Full Text] [Related]
51. [Chemical surveillance in the industrial environment]. Conso F Rev Prat; 1987 Apr; 37(23):1321-5. PubMed ID: 3602879 [No Abstract] [Full Text] [Related]
52. Current French system of post-marketing drug surveillance. Albengres E; Gauthier F; Tillement JP Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):312-4. PubMed ID: 2387656 [TBL] [Abstract][Full Text] [Related]
53. With more follow-up. Prescrire Int; 2011 Feb; 20(113):32. PubMed ID: 21488585 [No Abstract] [Full Text] [Related]
54. [Drug surveillance: the concept, the need and methods]. Moreno González A An R Acad Nac Med (Madr); 1992; 109(1):197-218; discussion 218-20. PubMed ID: 1463138 [No Abstract] [Full Text] [Related]
55. [Detection of drug side effects at the Heidelberg Medical Clinic]. Jacubeit T; Drisch D Verh Dtsch Ges Inn Med; 1989; 95():690-3. PubMed ID: 2603505 [No Abstract] [Full Text] [Related]
56. [Postmarketing surveillance of adverse reactions of drugs]. Polli EE; Cortellaro M Ann Ital Med Int; 1989; 4(1):1-9. PubMed ID: 2702012 [No Abstract] [Full Text] [Related]
57. [Post-marketing surveillance of drugs: epidemiologic approach]. Stanulović M; Jakovljević V; Sabo A Med Pregl; 1987; 40(11-12):573-7. PubMed ID: 3331415 [No Abstract] [Full Text] [Related]
58. Advantages of adverse-effect reporting by patients. Prescrire Int; 2011 Mar; 20(114):70. PubMed ID: 21648228 [No Abstract] [Full Text] [Related]
59. Use of an algorithm to evaluate published reports of adverse drug reactions. Case B; Oszko MA Am J Hosp Pharm; 1991 Jan; 48(1):121-2. PubMed ID: 2000870 [No Abstract] [Full Text] [Related]
60. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions. Fraunfelder FW; Fraunfelder FT Am J Ophthalmol; 2007 Jan; 143(1):145-149. PubMed ID: 17188050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]